A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...

In the first half of 2025, researchers around the world have published a wave of peer-reviewed studies examining the effects ...

Welcome to Caregiver Relief Podcast, the show where we explore real world strategies, stories, and support for family ...

UC San Diego scientists have created a gene therapy that goes beyond masking Alzheimer’s symptoms—it may actually restore ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Alzheimer’s Under the Microscope The researchers used a mouse model known as 5xFAD, which is often used to study Alzheimer’s because it rapidly develops amyloid beta plaques and memory problems.

Studies show that close to two-thirds of Alzheimer’s patients are women. According to a Medical News Today article published on August 4, 2021, about 75% of people experience memory problems ...

A breakthrough study has uncovered the role of the SIRT2 enzyme in Alzheimer’s, showing how astrocytes may fuel memory loss and brain decline. (CREDIT: CC BY-SA 4.0) ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Researchers from the US, UK, and Spain tracked more than 10,000 people over the age of 50. Higher levels of well-being may ...

Early dementia symptom 'often' includes 2 noticeable changes – not memory loss While many are aware of memory problems as a sign of dementia, there's another early symptom of the disease to be ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...